Overwhelming Evidence for a Major Role for Herpes Simplex Virus Type 1 (HSV1) in Alzheimer’s Disease (AD); Underwhelming Evidence against DOI Creative Commons
Ruth F. Itzhaki

Vaccines, Год журнала: 2021, Номер 9(6), С. 679 - 679

Опубликована: Июнь 21, 2021

This review describes investigations of specific topics that lie within the general subject HSV1’s role in AD/dementia, published last couple years. They include studies on following: relationship HSV1 to AD using neural stem cells; apparent protective effects treatment infection or VZV with antivirals prior onset dementia; putative involvement AD/dementia; possible human herpes virus 6 (HHV6) AD; seemingly reduced risk dementia after vaccination diverse types vaccine, and association shown some vaccine frequency reactivation; anti-HSV serum antibodies supporting linkage brain APOE-ε4 carriers, between APOE cognition, AD/dementia. The conclusions are there is now overwhelming evidence for role—probably causal—in AD, when it present further should be made prevention disease by vaccination, prolonged antiviral before onset.

Язык: Английский

Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response DOI Creative Commons
Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei

и другие.

Journal of Experimental & Clinical Cancer Research, Год журнала: 2022, Номер 41(1)

Опубликована: Март 22, 2022

Abstract Prostate cancer is a leading cause of death worldwide and new estimates revealed prostate as the in men 2021. Therefore, strategies are pertinent treatment this malignant disease. Macroautophagy/autophagy “self-degradation” mechanism capable facilitating turnover long-lived toxic macromolecules organelles. Recently, attention has been drawn towards role autophagy how its modulation provides effective therapy. In present review, we provide mechanistic discussion cancer. Autophagy can promote/inhibit proliferation survival cells. Besides, metastasis cells affected (via induction inhibition) by autophagy. affect response to therapy such chemotherapy radiotherapy, given close association between apoptosis. Increasing evidence demonstrated that upstream mediators AMPK, non-coding RNAs, KLF5, MTOR others regulate Anti-tumor compounds, for instance phytochemicals, dually inhibit or induce For improving therapy, nanotherapeutics chitosan nanoparticles have developed. With respect context-dependent cancer, genetic tools siRNA CRISPR-Cas9 be utilized targeting autophagic genes. Finally, these findings translated into preclinical clinical studies improve prognosis patients. Graphical abstract

Язык: Английский

Процитировано

110

Mitochondria, energy, and metabolism in neuronal health and disease DOI
Diogo Trigo, Catarina Avelar, Miguel X. Fernandes

и другие.

FEBS Letters, Год журнала: 2022, Номер 596(9), С. 1095 - 1110

Опубликована: Янв. 28, 2022

Mitochondria are associated with various cellular activities critical to homeostasis, particularly in the nervous system. The plastic architecture of mitochondrial network and its dynamic structure play crucial roles ensuring that varying energetic demands rapidly met maintain neuronal axonal energy homeostasis. Recent evidence associates aging neurodegeneration anomalous metabolism as age‐dependent alterations now believed occur prior neurodegeneration. brain has a high demand, which makes it sensitive dysfunction. Distinct events causing oxidative stress or disruption homeostasis can trigger neuropathology. This review explores bioenergetic hypothesis for neurodegenerative pathomechanisms, discussing factors leading age‐related hypometabolism contribution cognitive decline. research on healthy system cells, response stress, how is affected by pathology, well current contributions novel therapeutic approaches will be highlighted.

Язык: Английский

Процитировано

108

Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria DOI
Prashanth Gowda, P. Hemachandra Reddy, Subodh Kumar

и другие.

Ageing Research Reviews, Год журнала: 2021, Номер 73, С. 101529 - 101529

Опубликована: Ноя. 20, 2021

Язык: Английский

Процитировано

104

Role of Nrf2 in aging, Alzheimer’s and other neurodegenerative diseases DOI Creative Commons
Mathew George, Matthan Tharakan,

John Culberson

и другие.

Ageing Research Reviews, Год журнала: 2022, Номер 82, С. 101756 - 101756

Опубликована: Окт. 13, 2022

Язык: Английский

Процитировано

97

Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease DOI Creative Commons
Yun Li, Xiaohuan Xia, Yi Wang

и другие.

Journal of Neuroinflammation, Год журнала: 2022, Номер 19(1)

Опубликована: Окт. 6, 2022

Abstract Alzheimer's disease (AD) is the most common neurodegenerative in elderly globally. Emerging evidence has demonstrated microglia-driven neuroinflammation as a key contributor to onset and progression of AD, however, mechanisms that mediate remain largely unknown. Recent studies have suggested mitochondrial dysfunction including DNA (mtDNA) damage, metabolic defects, quality control (QC) disorders precedes microglial activation subsequent neuroinflammation. Therefore, an in-depth understanding relationship between AD important unveil pathogenesis develop effective approaches for early diagnosis treatment. In this review, we summarized current progress roles mtDNA, metabolism, QC changes provide comprehensive thoughts targeting mitochondria potential therapeutic strategies AD.

Язык: Английский

Процитировано

81

Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments DOI
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar

и другие.

Neuroscience & Biobehavioral Reviews, Год журнала: 2022, Номер 144, С. 104961 - 104961

Опубликована: Ноя. 14, 2022

Язык: Английский

Процитировано

75

Autophagy in health and disease: From molecular mechanisms to therapeutic target DOI Creative Commons
Guang Lu, Yu Wang, Yin Shi

и другие.

MedComm, Год журнала: 2022, Номер 3(3)

Опубликована: Июль 10, 2022

Macroautophagy/autophagy is an evolutionally conserved catabolic process in which cytosolic contents, such as aggregated proteins, dysfunctional organelle, or invading pathogens, are sequestered by the double-membrane structure termed autophagosome and delivered to lysosome for degradation. Over past two decades, autophagy has been extensively studied, from molecular mechanisms, biological functions, implications various human diseases, development of autophagy-related therapeutics. This review will focus on latest research, covering mechanisms control biogenesis autophagosome-lysosome fusion, upstream regulatory pathways including AMPK MTORC1 pathways. We also provide a systematic discussion implication cancer, neurodegenerative disorders (Alzheimer disease, Parkinson Huntington's Amyotrophic lateral sclerosis), metabolic diseases (obesity diabetes), viral infection especially SARS-Cov-2 COVID-19, cardiovascular (cardiac ischemia/reperfusion cardiomyopathy), aging. Finally, we summarize pharmacological agents that have therapeutic potential clinical applications via targeting pathway. It believed decades hard work research eventually bring real tangible benefits improvement health diseases.

Язык: Английский

Процитировано

69

Biological and neurological activities of astaxanthin (Review) DOI Creative Commons

Pan Si,

Chenkai Zhu

Molecular Medicine Reports, Год журнала: 2022, Номер 26(4)

Опубликована: Авг. 8, 2022

Astaxanthin is a lipid‑soluble carotenoid produced by various microorganisms and marine animals, including bacteria, yeast, fungi, microalgae, shrimps lobsters. has antioxidant, anti‑inflammatory anti‑apoptotic properties. These characteristics suggest that astaxanthin health benefits protects against diseases. Owing to its ability cross the blood‑brain barrier, received attention for protective effects neurological disorders, Alzheimer's disease, Parkinson's amyotrophic lateral sclerosis, cerebral ischemia/reperfusion, subarachnoid hemorrhage, traumatic brain injury, spinal cord cognitive impairment neuropathic pain. Previous studies on of are mostly based animal models cellular experiments. Thus, biological humans underlying mechanisms still not fully understood. The present review summarizes neuroprotective astaxanthin, explores action draws potential clinical implications as therapeutic agent.

Язык: Английский

Процитировано

69

Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications DOI

Mallikarjuna Nimgampalle,

Harshini Chakravarthy, Sapana Sharma

и другие.

Ageing Research Reviews, Год журнала: 2023, Номер 89, С. 101994 - 101994

Опубликована: Июнь 28, 2023

Язык: Английский

Процитировано

68

N1-methylation of adenosine (m1A) in ND5 mRNA leads to complex I dysfunction in Alzheimer’s disease DOI Creative Commons

Marko Jörg,

Johanna E. Plehn,

Marco Kristen

и другие.

Molecular Psychiatry, Год журнала: 2024, Номер 29(5), С. 1427 - 1439

Опубликована: Янв. 29, 2024

Abstract One mechanism of particular interest to regulate mRNA fate post-transcriptionally is modification. Especially the extent m 1 A methylation highly discussed due methodological differences. However, one single site in mitochondrial ND5 was unanimously reported by different groups. a subunit complex I respiratory chain. It considered essential for coupling oxidation and proton transport. Here we demonstrate that this might be involved pathophysiology Alzheimer’s disease (AD). pathological hallmarks neurodegenerative dysfunction, mainly induced Amyloid β (Aβ). Aβ disturbs functions IV molecular dysfunction still not fully understood. We found enhanced an AD cell model as well patients. Formation catalyzed increased TRMT10C protein levels, leading translation repression ND5. As consequence, here demonstrated first time, leads dysfunction. Our findings suggest newly identified Aβ-induced

Язык: Английский

Процитировано

17